Attached files

file filename
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadamis-10k_0627.htm
EX-10.46 - LICENSE AGREEMENT DATED JANUARY 2, 2008, WITH WISCONSIN ALUMNI RESEARCH FOUNDATION - Adamis Pharmaceuticals Corpex-10_46.htm
EX-10.45 - LICENSE AGREEMENT DATED JANUARY 26, 2007, WITH WISCONSIN ALUMNI RESEARCH FOUNDATION - Adamis Pharmaceuticals Corpex-10_45.htm
EX-10.47 - FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT - Adamis Pharmaceuticals Corpex-10_47.htm
EX-10.44 - LICENSE AGREEMENT DATED JANUARY 26, 2007, WITH WISCONSIN ALUMNI RESEARCH FOUNDATION - Adamis Pharmaceuticals Corpex-10_44.htm
EX-10.43 - LICENSE AGREEMENT BETWEEN ADAMIS, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AND DANA-FARBER CANCER INSTITUTE, INC. - Adamis Pharmaceuticals Corpex-10_43.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex-31_1.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex-32_1.htm
EX-21.1 - SUBSIDIARIES LIST - Adamis Pharmaceuticals Corpex-21_1.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex-32_2.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex-31_2.htm


 
EXHIBIT 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
       As independent registered public accountants, we hereby consent to the incorporation by reference in the following registration statements of our report dated July 6, 2011 included in Adamis Pharmaceutical Corporation's Form 10-K for the year ended March 31, 2011.
 
       *    Registration statement on Form S-8, SEC file numner 333-159229, as filed with the Securities and Exchange Commission on May 19, 2009,
 
       *    Registration statement on Form S-8, SEC file number 333-169106, as filed with the Securitieis and Exchange Commission on August 30, 2010.
 
 
/s/ Mayer Hoffman McCann P.C.
 
MAYER HOFFMAN MCCANN PC
Certified Public Accountants
Boca Raton, Florida
 
July 6, 2011